The US data continues to be going in the right direction with cases decreased by another 10% this past week.
Over last weekend, the US FDA and CDC jointly announced lifting the “pause” on the use of the Johnson & Johnson COVID-19 vaccine.
After 5 consecutive weeks of a slow upward trend in U.S. cases, we have seen nearly a 12% drop in the case rates over the previous week.
The CDC and FDA recommended an immediate pause in the use of the Johnson & Johnson single dose COVID-19 vaccine.
In the United States, the nation is still on track to be able to deliver the vaccine to all willing adults over the next 4 to 6 weeks.
The CDC announced data regarding the efficacy of the major vaccines against infections and infectiousness exceeds 90%.
We have not seen the predicted 4th wave in March, what we have seen is a flattening of what had been a steep decline in the number of cases.
Over the last week, the overall rate of the United States is only down by about 5%, but half of the states are actually ticking upward again.
It now appears that the pace of vaccination and the movement towards herd immunity has blunted the effect of more virulent COVID-19 variants.
The most important news this week is the approval and release of the Johnson & Johnson single-dose vaccine for COVID-19.